Research Group
神经递质与肿瘤微环境研究组
日期:2018-03-07研究方向
1.肿瘤的系统性调控
2.神经递质-激素-免疫系统对肿瘤发生发展的调控
3.器官间交流在肿瘤发生发展中的作用
团队成员
工作人员
李 军 博士 junli@shsci.org
聂惠贞 博士 hznie@shsci.org
杨小妹 博士 xmyang@shsci.org
张雪莉 博士 xlzhang@shsci.org
蒋书恒 博士 shjiang@shsci.org
张艳丽 博士 ylzhang@shsci.org
朱 蕾 博士 lzhu@shsci.org
姚琳丽 博士 llyao@shsci.org
李冬雪 博士 dxli@shsci.org
胡立鹏 博士 lphu@shsci.org
博士后
李 庆 博士 lq8710@aliyun.com
学生
朱莉莉 博士研究生 21418093@zju.edu.cn
黄 杉 博士研究生 294849734@qq.com
张 姗 博士研究生 zhangs0049@163.com
周开霞 硕士研究生 lostdeer@126.com
张一帆 硕士研究生 ZhangYifan2018@sjtu.edu.cn
孙 悦 硕士研究生 mmmoon@sjtu.edu.cn
周耀麒 硕士研究生 zhouyq1997@163.com
盖严支 硕士研究生 yanzhi_gai@163.com
潘 泓 硕士研究生 ph980829@163.com
代表性论文
1. Wang X, Hu LP, Qin WT, Yang Q, Chen DY, Li Q, Zhou KX, Huang PQ, Xu CJ, Li J, Yao LL, Wang YH, Tian GA, Yang JY, Yang MW, Liu DJ, Sun YW, Jiang SH, Zhang XL, Zhang ZG*. Identification of a subset of immunosuppressive P2RX1-negative neutrophils in pancreatic cancer liver metastasis. Nature Communications, 2021 Jan 8; 12(1):174
2. Zhang N, Sundquist J, Sundquist K, Zhang ZG, Ji J. Combined Use of Aspirin and Selective Serotonin Reuptake Inhibitors Is Associated With Lower Risk of Colorectal Cancer: A Nested Case-Control Study. Am J Gastroenterol. 2021 Feb 26.
3. Jiang SH, Hu LP, Wang X, Li J, Zhang ZG. Neurotransmitters: emerging targets in cancer. Oncogene. 2020 Jan;39(3):503-515.
4. Yang MW, Tao LY, Jiang YS, Yang JY, Huo YM, Liu DJ, Li J, Fu XL, He R, Lin C, Liu W, Zhang JF, Hua R, Li Q, Jiang SH, Hu LP, Tian GA, Zhang XX, Niu N, Lu P, Shi J, Xiao GG, Wang LW, Xue J, Zhang ZG*, Sun YW. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2020, 80, 1991-2003.
5. Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, Zhang C, Yang JY, Dong FY, Dai M, Hu LP, Li J, Li Q, Wang YH, Yang XM, Zhang YL, Nie HZ, Zhu L, Zhang XL, Tian GA, Zhang XX, Cao XY, Tao LY, Huang S, Jiang YS, Hua R, Luo KQ, Gu JR, Sun YW, Hou SW, Zhang ZG*. GABRP regulates chemokine signaling, macrophage recruitment, and tumor progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signaling in a GABA-independent manner. Gut, 2019 Nov;68(11):1994-2006.
6. Hu LP, Zhang XX, Jiang SH, Tao LY, Li Q, Zhu LL, Yang MW, Huo YM, Jiang YS, Tian GA, Cao XY, Zhang YL, Yang Q, Yang XM, Wang YH, Li J, Xiao GG, Sun YW, Zhang ZG*. Targeting Purinergic Receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin Cancer Res, 2019 Feb 15;25(4):1318-1330.
7. Yang XM, Cao XY, He P, Li J, Feng MX, Zhang YL, Zhang XL, Wang YH, Yang Q, Zhu L, Nie HZ, Jiang SH, Tian GA, Zhang XX, Liu Q, Ji J, Zhu X, Xia Q, Zhang ZG*. Overexpression of Rac GTPase activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Gastroenterology, 2018 Oct;155(4):1233-1249.
8. Zhang YL, Li Q, Yang XM, Fang F, Li J, Wang YH, Yang Q, Zhu L, Nie HZ, Zhang XL, Feng MX, Jiang SH, Tian GA, Hu LP, Lee HY, Lee SJ, Xia Q, Zhang ZG*, SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways. Cancer Research, 2018 May 1;78(9):2305-2317.
9. Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX, Li Q, Pang XF, Huo YM, Li J, Zhang JF, Lee HY, Lee SJ, Qin WX, Gu JR, Sun YW, Zhang ZG*. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology, 2017 Jul;153(1):277-291.
10. Nie H, Li J, Yang XM, Cao QZ, Feng MX, Xue F, Wei L, Qin W, Gu J, Xia Q, Zhang ZG*. Mineralocorticoid receptor suppresses cancer progression and Warburg effect by modulating miR-338-3p-PKLR axis in hepatocellular carcinoma. Hepatology, 2015 Oct;62(4):1145-59.
11. Li J, Yang XM, Wang YH, Feng MX, Liu XJ, Zhang YL, Huang S, Wu Z, Xue F, Qin WX, Gu JR, Xia Q, Zhang ZG*. Monoamine oxidase A suppresses Hepatocellular Carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling. Journal of Hepatology, 2014 Jun;60(6):1225-34.
12. Zhao SJ, Jiang YQ, Xu NW, Li Q, Zhang Q, Wang SY, Li J, Wang YH, Zhang YL, Jiang SH, Wang YJ, Huang YJ, Zhang XX, Tian GA, Zhang CC, Lv YY, Dai M, Liu F, Zhang R, Zhou D, Zhang ZG*. SPARCL1 suppresses osteosarcoma metastasis and recruits M1 macrophages by autocrine activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex. Oncogene, 2018 Feb 22;37(8):1049-1061
所获项目
1. 国家自然科学基金面上项目,81672358,pre-mRNA剪接因子SF3B4通过可变剪接调
控脂质代谢促进肝癌发展的分子机制研究,2017/01-2020/12,57万元,在研,主持
2. 国家自然科学基金面上项目,81472678,甲基化介导的胞外基质蛋白Dermatoponti
n基因沉默促进肝癌的侵袭转移,2015/01-2018/12,78万元,在研,主持
3. 国家科技重大专项子课题,2013ZX10002007-006,指导肝癌化疗方案的单胺氧化酶
(MAOA)、分泌蛋白CTHRC1血清检测试剂,2013/01-2015/12,已结题,主持
4. 国家高技术研究发展计划,2014AA020609,胰腺癌的蛋白质分子网络研究,2014/0
1-2016/12,已结题,参与
5. 国家自然科学基金面上项目,81071738,整合素α9β1在肝癌与其微环境相互作用
中的研究,2011/01-2013/12,32万元,已结题,主持
6. 国家自然科学基金重大研究计划,91029738,非可控性炎症恶性转化的调控网络及
其分子机制,2011/01-2013/12,70万元,已结题,参与
获得专利等其他
1.MAOA基因在肝癌治疗中的应用,专利号:ZL201210181654.X,张志刚,李军,顾健人
2.芳香化酶抑制剂在制备抗肝硬化或抗肝纤维化的药物中的应用,专利号:ZL 201110418167.6,张志刚,覃文新,王亚辉